HESSEL PHARMA ApS: Financial statements 2019
CVR: 32560903
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
HESSEL PHARMA ApS (CVR 32560903) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 3,305,350 and a net result of DKK 2,575,472 compared with DKK 30,406 the year before. Equity in the 2019 report amounted to DKK 635,471. The solvency ratio was 46%.
- Gross Profit
- DKK 3,305,350
- Profit/Loss
- DKK 2,575,472
- Equity
- DKK 635,471
- Total Assets
- DKK 1,381,649
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 3.3M | 2.6M | 635K | 0 |
| 2018 | - | -154K | 30K | -1.9M | 0 |
| 2017 | - | -479K | -93K | -2M | 0 |
| 2016 | - | -336K | -379K | -1.9M | - |
| 2015 | - | -710K | -724K | -1.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
HESSEL PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -154,369, and the net result was DKK 30,406.
About HESSEL PHARMA ApS
HESSEL PHARMA ApS was a Danish company of the type Anpartsselskab based in Stenløse, founded in 2009. The company has been dissolved on 7 December 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2013). In 2019, the company reported a gross profit of DKK 3,305,350 and a net result of DKK 2,575,472 compared with DKK 30,406 the year before. Equity in the 2019 report amounted to DKK 635,471.